Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an ...

The FDA on Tuesday signed off on Supernus Pharmaceuticals’ apomorphine hydrochloride injection—to be marketed under the brand ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

ROCK veteran Ozzy Osbourne will play his final EVER show this summer, amid his worsening battle with Parkinson’s disease. The ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's ...

Trusted resource of information on Alzheimer's Disease that includes articles, news, videos, animations, quizzes, calculators ...

Now, a new study from Renmin Hospital of Wuhan University provides strong evidence that kidney failure may also contribute to the development of Parkinson’s disease by triggering the spread of ...

A gold-standard University College of London study found a type of weight-loss jab had no benefit in alleviating a condition ...

William F. Parent, 74, of Middletown, Rhode Island, died peacefully on January 14, 2025, surrounded by family and friends after a ten-year battle with Parkinson’s Disease. Born in Lewiston, ME on June ...

Traditional deep brain stimulation surgery can take up to 10 hours to complete, with the patient wide awake. This robotic ...

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

University of Tasmania and Parkinson's Research Foundation bridge gap in Parkinson's knowledge with first of its kind resourceFree online course ...